BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28081741)

  • 1. Depletion of NFBD1/MDC1 Induces Apoptosis in Nasopharyngeal Carcinoma Cells Through the p53-ROS-Mitochondrial Pathway.
    Wang Z; Liao K; Zuo W; Liu X; Qiu Z; Gong Z; Liu C; Zeng Q; Qian Y; Jiang L; Bu Y; Hong S; Hu G
    Oncol Res; 2017 Jan; 25(1):123-136. PubMed ID: 28081741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
    Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
    Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors.
    Wang Z; Zuo W; Zeng Q; Qian Y; Li Y; Liu C; Wang J; Zhong S; Bu Y; Hu G
    J Biomed Sci; 2019 Feb; 26(1):14. PubMed ID: 30717758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFBD1/MDC1 participates in the regulation of proliferation and apoptosis in human laryngeal squamous cell carcinoma.
    Liu X; Qiu Z; Wang Z; Zuo W; Gong Z; Liu C; Zeng Q; Qian Y; Jiang L; Li Y; Bu Y; Hu G
    Clin Transl Oncol; 2018 Apr; 20(4):534-541. PubMed ID: 28921460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing NFBD1/MDC1 enhances the radiosensitivity of human nasopharyngeal cancer CNE1 cells and results in tumor growth inhibition.
    Wang Z; Zeng Q; Chen T; Liao K; Bu Y; Hong S; Hu G
    Cell Death Dis; 2015 Aug; 6(8):e1849. PubMed ID: 26247734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53.
    Wilson KA; Colavito SA; Schulz V; Wakefield PH; Sessa W; Tuck D; Stern DF
    Mol Cancer Res; 2011 Jun; 9(6):766-81. PubMed ID: 21551225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells.
    Yang Z; Bu Y; Wang C; Liu G; Song F
    Mol Cell Biochem; 2010 Sep; 342(1-2):1-6. PubMed ID: 20364298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer.
    Yuan C; Bu Y; Wang C; Yi F; Yang Z; Huang X; Cheng L; Liu G; Wang Y; Song F
    Mol Cell Biochem; 2012 Jan; 359(1-2):333-46. PubMed ID: 21853275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.
    Nakanishi M; Ozaki T; Yamamoto H; Hanamoto T; Kikuchi H; Furuya K; Asaka M; Delia D; Nakagawara A
    J Biol Chem; 2007 Aug; 282(31):22993-3004. PubMed ID: 17535811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63.
    Chow SE; Wang JS; Chuang SF; Chang YL; Chu WK; Chen WS; Chen YW
    Cancer Gene Ther; 2010 Dec; 17(12):872-82. PubMed ID: 20725098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.
    Zhao M; Fan J; Liu Y; Yu Y; Xu J; Wen Q; Zhang J; Fu S; Wang B; Xiang L; Feng J; Wu J; Yang L
    Int J Oncol; 2016 Feb; 48(2):756-64. PubMed ID: 26691054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
    Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
    Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
    Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.
    Li Y; Tang X; He Q; Yang X; Ren X; Wen X; Zhang J; Wang Y; Liu N; Ma J
    PLoS Genet; 2016 Jul; 12(7):e1006183. PubMed ID: 27428374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
    Yang H; Zhao R; Lee MH
    Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma.
    Li S; Mao Y; Zhou T; Luo C; Xie J; Qi W; Yang Z; Ma J; Gao G; Yang X
    Oncotarget; 2016 May; 7(22):32408-20. PubMed ID: 27083052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
    Ando K; Ozaki T; Hirota T; Nakagawara A
    PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA Highly Upregulated in Liver Cancer Activates p53-p21 Pathway and Promotes Nasopharyngeal Carcinoma Cell Growth.
    Jiang X; Liu W
    DNA Cell Biol; 2017 Jul; 36(7):596-602. PubMed ID: 28445086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.